1. Home
  2. Shareholder and Investor Information
  3. Understanding RaQualia Pharma! RaQualia FAQ
  4. How Does RaQualia Earn Revenues?

Shareholder and Investor Information

How Does RaQualia Earn Revenues?

Revenue Model

RaQualia Pharma earns revenues by licensing its intellectual property rights, for example the development compounds for new drugs, to pharmaceutical companies. Our licensing strategy is to offer licensing at every stage in our business.

Licensing Licensing the right to use the development compound
AUpfront Payment Revenue received from licensing IP rights for development compounds to the pharmaceutical companies
BMilestone Payment Revenue received when each agreed milestone event is achieved
CRoyalty Payment Revenue received at a set percentage of sales after the product is launched on the market
Research Cooperation Revenue Revenue received as consideration for providing RaQualia's research results at the beginning of joint research, based on the terms of the joint research, and revenue received as consideration for services provided during the joint research.
  • Previous
  • Next
  • FAQ

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Quality Policy
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Access
Press Release
Research & Development
Collaboration
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Anidulafungin
Ziprasidone
Dalbavancin
Potassium-Competitive Acid Blocker
5-HT4 Partial Agonist
5-HT2B Antagonist
Motilin Receptor Agonist
Licensing Status
Shareholder and Investor Information
Vision, Management Principle and Culture
Corporate Governance
Outline of Securities Matters
IR Library
IR Calendar
Disclaimer
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release
Topics